Common Contracts
1 similar Clinical Trial Agreement contracts
FIRST AMENDMENT TO CLINICAL TRIAL AGREEMENT PRVNÍ DODATEK KE SMLOUVĚ O KLINICKÉM HODNOCENÍClinical Trial Agreement • October 21st, 2020
THIS FIRST AMENDMENT TO CLINICAL TRIAL AGREEMENT (this “Amendment”) is made and entered into by and between Covance Clinical and Periapproval Services Limited, Osprey House, Westacott Way, Maidenhead, SL6 3QH, UK, Registered in England, Company No 02022667, represented by XXXXX XXXXXXXXXXXX (hereinafter referred to as “Covance”); and Fakultni nemocnice Olomouc, I.P.Pavlova 6, 775 20 Olomouc, Czech Republic, ID No.: 00098892, Tax No.: CZ 00098892, represented by Prof. MUDr. Roman Havlík, Ph.D., (hereinafter referred to as “Institution”), (Covance and Institution collectively the “Parties”), effective as of 25 May 2018, the date on which the GDPR entered into force (the “Amendment Effective Date”). TENTO PRVNÍ DODATEK SMLOUVY O KLINICKÉM HODNOCENÍ (dále jen „Dodatek“) uzavírají Covance Clinical and Periapproval Services Limited, Osprey House, Westacott Way, Maidenhead, SL6 3QH, UK, Společnost registrovaná v Anglii, IČ: 02022667, zastoupená XXXXXXX XXXXXXXXX, (dále jen "Covance"); a
